{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T16:54:28Z","timestamp":1649091268010},"reference-count":14,"publisher":"Europa Digital & Publishing","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["EuroIntervention"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.4244\/eijv11i5a120","type":"journal-article","created":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T23:29:29Z","timestamp":1447198169000},"page":"605-608","source":"Crossref","is-referenced-by-count":0,"title":["How should I treat a significant and inoperable left main coronary atherosclerotic disease (LMCAD) in the setting of a severely depressed left ventricular systolic function and severe aorto-iliac atherosclerotic disease?"],"prefix":"10.4244","volume":"11","author":[{"given":"Akram W.","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piyanart","family":"Preeyanont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Tanveer","family":"Rab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadi","family":"Al-Rashid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heike A.","family":"Hildebrandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Kahlert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Deharo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Cuisset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2774","reference":[{"key":"key-2015920211936-0","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.4244\/EIJV10I10A206","article-title":"Tools & Techniques- clinical: percutaneous catheter-based left ventricular support using the Impella CP.","volume":"10","author":"Al-Rashid F.","year":"2015","journal-title":"EuroIntervention."},{"key":"key-2015920211936-1","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1016\/j.jacc.2014.04.015","article-title":"Caval-aortic access to allow transcatheter aortic valve replacement in otherwise ineligible patients: initial human experience.","volume":"63","author":"Greenbaum AB.","year":"2014","journal-title":"J Am Coll Cardiol."},{"key":"key-2015920211936-2","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/ccd.23403","article-title":"Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: the USpella Registry.","volume":"80","author":"Maini B.","year":"2012","journal-title":"Catheter Cardiovasc Interv."},{"key":"key-2015920211936-3","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1540-8183.2011.00696.x","article-title":"Percutaneous left axillary artery approach for Impella 2.5 liter circulatory support for patients with severe aortoiliac arterial disease undergoing high-risk percutaneous coronary intervention.","volume":"25","author":"Lotun K.","year":"2012","journal-title":"J Interv Cardiol."},{"key":"key-2015920211936-4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ijcard.2007.12.112","article-title":"A combined surgical and percutaneous approach through the axillary artery to introduce the Impella LP5.0 for short-term circulatory support.","volume":"134","author":"Lam K.","year":"2009","journal-title":"Int J Cardiol."},{"key":"key-2015920211936-5","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1161\/CIRCULATIONAHA.112.098194","article-title":"A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study.","volume":"126","author":"O\u2019Neill WW.","year":"2012","journal-title":"Circulation."},{"key":"key-2015920211936-6","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1016\/j.jacc.2011.08.007","article-title":"2011 ACCF\/AHA\/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.","volume":"58","author":"Levine GN.","year":"2011","journal-title":"J Am Coll Cardiol."},{"key":"key-2015920211936-7","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.4244\/EIJV10I10A206","article-title":"Tools & Techniques- clinical: percutaneous catheter-based left ventricular support using the Impella CP.","volume":"10","author":"Al-Rashid F.","year":"2015","journal-title":"EuroIntervention."},{"key":"key-2015920211936-8","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1016\/j.jacc.2014.04.015","article-title":"Caval-aortic access to allow transcatheter aortic valve replacement in otherwise ineligible patients: initial human experience.","volume":"63","author":"Greenbaum AB.","year":"2014","journal-title":"J Am Coll Cardiol."},{"key":"key-2015920211936-9","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/ccd.23403","article-title":"Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: the USpella Registry.","volume":"80","author":"Maini B.","year":"2012","journal-title":"Catheter Cardiovasc Interv."},{"key":"key-2015920211936-10","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1540-8183.2011.00696.x","article-title":"Percutaneous left axillary artery approach for Impella 2.5 liter circulatory support for patients with severe aortoiliac arterial disease undergoing high-risk percutaneous coronary intervention.","volume":"25","author":"Lotun K.","year":"2012","journal-title":"J Interv Cardiol."},{"key":"key-2015920211936-11","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ijcard.2007.12.112","article-title":"A combined surgical and percutaneous approach through the axillary artery to introduce the Impella LP5.0 for short-term circulatory support.","volume":"134","author":"Lam K.","year":"2009","journal-title":"Int J Cardiol."},{"key":"key-2015920211936-12","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1161\/CIRCULATIONAHA.112.098194","article-title":"A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study.","volume":"126","author":"O\u2019Neill WW.","year":"2012","journal-title":"Circulation."},{"key":"key-2015920211936-13","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1016\/j.jacc.2011.08.007","article-title":"2011 ACCF\/AHA\/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.","volume":"58","author":"Levine GN.","year":"2011","journal-title":"J Am Coll Cardiol."}],"container-title":["EuroIntervention"],"original-title":[],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T08:15:11Z","timestamp":1567325711000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.pcronline.com\/eurointervention\/88th_issue\/120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["EIJV11I5A120"],"URL":"https:\/\/doi.org\/10.4244\/eijv11i5a120","relation":{},"ISSN":["1774-024X"],"issn-type":[{"value":"1774-024X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]}}}